Literature DB >> 24803233

Extra-articular manifestations in psoriatic arthritis patients.

Rosario Peluso1, Salvatore Iervolino, Maria Vitiello, Vincenzo Bruner, Gelsy Lupoli, Matteo Nicola Dario Di Minno.   

Abstract

Psoriatic arthritis (PsA) is an inflammatory rheumatic disorder, associated with skin and/or nail psoriasis. It has been included in the spondyloarthropathies (SpA) group, with which it shares clinical, radiologic, and serologic features and familial and genetic relationship. Inclusion of disease among SpA is also based on their striking points of similarity for extra-articular manifestations (EAMs). The aim of study was to describe the EAMs in patients with PsA, evaluating the prevalence and clinical features associated with established and early PsA. The study was a retrospective analysis of case records of 387 PsA patients. Data recorded were demographic data, disease properties, laboratory tests, drug use, and presence of EAMs. Of 387 PsA patients, 190 have shown EAMs: 33.16 % had bowel involvement, 32.63 % ocular, 28.42 % cardiovascular, 25.79 % urogenital, 8.42 % skin (excluding psoriasis), 1.05 % pulmonary, and 0.53 % renal. A higher prevalence of EAMs was found in axial subset (p < 0.0001) and in established PsA patients (p = 0.03). The disease activity in PsA patients with EAMs was significantly higher (p < 0.0005). Smoker PsA patients had a significantly higher prevalence of EAMs than nonsmoker PsA patients (p < 0.0005). EAMs in PsA patients are common than expected and frequently associated with established form and axial subset. EAMs were more frequent in male gender, and the contemporary presence of male gender and axial subset showed a higher risk to develop EAMs. EAMS were more frequent in patients with a long disease duration and active disease. Moreover, these results suggest that in PsA patients, an initial checkup and a regular screening for EAMs are requested to ensure an appropriate management.

Entities:  

Mesh:

Year:  2014        PMID: 24803233     DOI: 10.1007/s10067-014-2652-9

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  48 in total

Review 1.  Extra-articular manifestations of ankylosing spondylitis: prevalence, characteristics and therapeutic implications.

Authors:  Abdellah El Maghraoui
Journal:  Eur J Intern Med       Date:  2011-07-13       Impact factor: 4.487

2.  Multiple pulmonary nodules in a male with psoriatic arthritis.

Authors:  A Manuel; Q Jones; J Wiggins
Journal:  Eur Respir Rev       Date:  2010-06

3.  Pulmonary involvement in ankylosing spondylitis.

Authors:  Percival D Sampaio-Barros; Elza Maria F P Cerqueira; Sílvio M Rezende; Lucimara Maeda; Roseneide A Conde; Verônica A Zanardi; Manoel Barros Bértolo; José Ribeiro de Menezes Neto; Adil M Samara
Journal:  Clin Rheumatol       Date:  2006-03-30       Impact factor: 2.980

Review 4.  Cardiovascular risk and inflammatory rheumatic diseases.

Authors:  Awal Alhusain; Ian N Bruce
Journal:  Clin Med (Lond)       Date:  2013-08       Impact factor: 2.659

5.  Impaired endothelial function in patients with ankylosing spondylitis.

Authors:  I Sari; T Okan; S Akar; H Cece; C Altay; M Secil; M Birlik; F Onen; N Akkoc
Journal:  Rheumatology (Oxford)       Date:  2005-10-04       Impact factor: 7.580

Review 6.  The assessment of disease activity and outcomes in psoriatic arthritis.

Authors:  A Kavanaugh; S Cassell
Journal:  Clin Exp Rheumatol       Date:  2005 Sep-Oct       Impact factor: 4.473

7.  Magnetic resonance imaging of nail unit in psoriatic arthritis.

Authors:  Ernesto Soscia; Raffaele Scarpa; Marco Amedeo Cimmino; Mariangela Atteno; Rosario Peluso; Cesare Sirignano; Luisa Costa; Salvatore Iervolino; Francesco Caso; Antonio Del Puente; Marco Salvatore; Andrea Soricelli
Journal:  J Rheumatol Suppl       Date:  2009-08

8.  Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease.

Authors:  S M Jones; J B Armas; M G Cohen; C R Lovell; G Evison; N J McHugh
Journal:  Br J Rheumatol       Date:  1994-09

Review 9.  Clinical aspects of the spondyloarthropathies.

Authors:  D D Gladman
Journal:  Am J Med Sci       Date:  1998-10       Impact factor: 2.378

10.  Psoriasis, psoriatic arthritis, or psoriatic disease?

Authors:  Raffaele Scarpa; Fabio Ayala; Nicola Caporaso; Ignazio Olivieri
Journal:  J Rheumatol       Date:  2006-02       Impact factor: 4.666

View more
  13 in total

Review 1.  Update on ankylosing spondylitis: current concepts in pathogenesis.

Authors:  Judith A Smith
Journal:  Curr Allergy Asthma Rep       Date:  2015-01       Impact factor: 4.806

Review 2.  Pleural effusion in psoriatic arthritis patients: a case series and review of the literature.

Authors:  Aliki I Venetsanopoulou; Theodora E Markatseli; Chrisoula Iliou; Zoi Tziortzioti; Maria I Argyropoulou; Alexandros A Drosos; Paraskevi V Voulgari
Journal:  Clin Rheumatol       Date:  2021-03-29       Impact factor: 2.980

Review 3.  Sex- and gender-related differences in psoriatic arthritis.

Authors:  Sanjana Tarannum; Ying-Ying Leung; Sindhu R Johnson; Jessica Widdifield; Vibeke Strand; Paula Rochon; Lihi Eder
Journal:  Nat Rev Rheumatol       Date:  2022-08-04       Impact factor: 32.286

Review 4.  Pharmacological treatment of spondyloarthritis: exploring the effectiveness of nonsteroidal anti-inflammatory drugs, traditional disease-modifying antirheumatic drugs and biological therapies.

Authors:  Francesco Caso; Luisa Costa; Antonio Del Puente; Matteo Nicola Dario Di Minno; Gelsy Lupoli; Raffaele Scarpa; Rosario Peluso
Journal:  Ther Adv Chronic Dis       Date:  2015-11       Impact factor: 5.091

5.  Cognitive impairment in patients with psoriatic arthritis.

Authors:  Leonardo Ogawara Kawamoto Lahoz Garcia; Armando Takao Suehiro Júnior; Deusimar Cristian Dos Santos Gómez; Gabriel Seiji Sato Yoshikawa; Caio Kumassaka Kamikoga; Bruno Kusznir Vitturi
Journal:  Acta Neurol Belg       Date:  2021-03-13       Impact factor: 2.396

Review 6.  An overview of psoriatic arthritis - epidemiology, clinical features, pathophysiology and novel treatment targets.

Authors:  Andreas Kerschbaumer; Karl H Fenzl; Ludwig Erlacher; Daniel Aletaha
Journal:  Wien Klin Wochenschr       Date:  2016-11-07       Impact factor: 1.704

7.  Extra-Articular Symptoms in Constellation with Selected Serum Cytokines and Disease Activity in Spondyloarthritis.

Authors:  Hanna Przepiera-Będzak; Katarzyna Fischer; Marek Brzosko
Journal:  Mediators Inflamm       Date:  2016-12-07       Impact factor: 4.711

8.  Low-dose modified-release prednisone in axial spondyloarthritis: 3-month efficacy and tolerability.

Authors:  Francesca Bandinelli; Francesco Scazzariello; Emanuela Pimenta da Fonseca; Mittermayer Barreto Santiago; Claudio Marcassa; Francesca Nacci; Marco Matucci Cerinic
Journal:  Drug Des Devel Ther       Date:  2016-11-14       Impact factor: 4.162

9.  Efficacy and safety of faecal microbiota transplantation in patients with psoriatic arthritis: protocol for a 6-month, double-blind, randomised, placebo-controlled trial.

Authors:  Maja Skov Kragsnaes; Jens Kjeldsen; Hans Christian Horn; Heidi Lausten Munk; Finn Moeller Pedersen; Hanne Marie Holt; Jens Kristian Pedersen; Dorte Kinggaard Holm; Henning Glerup; Vibeke Andersen; Ulrich Fredberg; Karsten Kristiansen; Robin Christensen; Torkell Ellingsen
Journal:  BMJ Open       Date:  2018-04-27       Impact factor: 2.692

Review 10.  Biomarkers of subclinical atherosclerosis in patients with psoriatic arthritis.

Authors:  Rosario Peluso; Francesco Caso; Marco Tasso; Vincenzo Sabbatino; Roberta Lupoli; Matteo Nicola Dario Di Minno; Francesco Ursini; Luisa Costa; Raffaele Scarpa
Journal:  Open Access Rheumatol       Date:  2019-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.